PROS1 and sarcopenia: The consumption of mitochondrial energy metabolism proteins and neuromuscular junction proteins is most significantly correlated with sarcopenia, suggesting that a treatment that simultaneously stimulates mitochondrial generation and inflammation may have the potential to treat sarcopenia (30).